Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables - Other: 2014-2025

Historic Receivables - Other for HUTCHMED (China) (HCM) over the last 1 years, with Jun 2025 value amounting to $21.5 million.

  • HUTCHMED (China)'s Receivables - Other rose 46.11% to $21.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $21.5 million, marking a year-over-year increase of 46.11%. This contributed to the annual value of $28.5 million for FY2023, which is 46.52% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Receivables - Other of $21.5 million as of Q2 2025, which was up 46.11% from $14.7 million recorded in Q2 2024.
  • In the past 5 years, HUTCHMED (China)'s Receivables - Other ranged from a high of $81.0 million in Q4 2021 and a low of $14.7 million during Q2 2024.
  • Moreover, its 3-year median value for Receivables - Other was $25.0 million (2023), whereas its average is $23.5 million.
  • Per our database at Business Quant, HUTCHMED (China)'s Receivables - Other soared by 190.18% in 2021 and then plummeted by 59.91% in 2023.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Receivables - Other stood at $81.0 million in 2021, then slumped by 34.33% to $53.2 million in 2022, then slumped by 46.52% to $28.5 million in 2023, then slumped by 49.75% to $14.7 million in 2024, then soared by 46.11% to $21.5 million in 2025.
  • Its Receivables - Other stands at $21.5 million for Q2 2025, versus $14.7 million for Q2 2024 and $28.5 million for Q4 2023.